IL&FS Investment Managers Limited has informed the Exchange regarding Outcome of Board Meeting held on February 13, 2026 for appointment of Ms. Jayashree Ramaswamy (DIN: 02235205) as an Additional Director in the category of Nominee Director (Non-Executive), pursuant to her nomination by the Holding Company, Infrastructure Leasing & Financial Services Limited (IL&FS)
IVC · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
IL&FS Investment Managers (IIML) held a board meeting on February 13, 2026 and approved three key items: (1) unaudited consolidated results for Q2/H1 FY26 ended September 30, 2025, where the group posted a profit after tax of Rs. 367.07 lakhs versus a loss of Rs. 225.17 lakhs in H1 FY25, and consolidated Q2 PAT of Rs. 344.06 lakhs (up from Rs. 146.84 lakhs); (2) unaudited standalone and consolidated results for Q3/9M FY26 ended December 31, 2025, where standalone Q3 swung to a loss of Rs. 159.34 lakhs (from a profit of Rs. 141.23 lakhs in Q3 FY25) though 9M standalone PAT remained strong at Rs. 2,599.77 lakhs driven by a one-time Rs. 2,873.25 lakh dividend in Q2; (3) appointment of Ms. Jayashree Ramaswamy, currently Group CFO of IL&FS, as Additional Non-Executive Nominee Director, nominated by holding company IL&FS, effective February 13, 2026 until the next AGM. The auditor (KKC & Associates) issued a qualified review report flagging the ongoing SFIO investigation against the IL&FS group, potential revenue overstatement at subsidiary APUIAML, and a material going-concern uncertainty due to sharply declining fee income and no new fund raises. The IL&FS board's ongoing process to sell its entire stake in IIML (via the December 2023 EoI) remains underway with interested bidders.
The Q3 standalone loss highlights the underlying business weakness as fee revenue dries up, but the group-level turnaround and dividend boost mask structural concerns. The auditor's going-concern flag and unresolved SFIO probe keep risk premium elevated. Nominee director appointment reinforces holding company oversight during the stake-sale process but offers no near-term operational catalyst.